The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Carbamazepine 400 mg Tablets

Azure Pharmaceuticals LtdPA22871/010/003

Main Information

Trade NameCarbamazepine 400 mg Tablets
Active SubstancesCarbamazepine
Dosage FormTablet
Licence HolderAzure Pharmaceuticals Ltd
Licence NumberPA22871/010/003

Group Information

ATC CodeN03AF01 carbamazepine


License statusAuthorised
Licence Issued30/10/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back